Each year, we honor outstanding individuals whose contributions to cancer research—through scientific discovery or corporate and philanthropic leadership—have significantly advanced our mission to conquer cancer through immunotherapy.
On Tuesday, November 14, 2017, the Cancer Research Institute will bestow its highest honors on Bill Anderson, Bruce Ratner, Rafi Ahmed, PhD, Thomas F. Gajewski, MD, PhD, and Shannon Turley, PhD, who, like CRI, are dedicated to fueling the development of immunotherapies for all forms of cancer.
Honoring
Bill Anderson
Chief Executive Officer, Genentech
Receiving the Oliver R. Grace Award for Distinguished Service in Advancing Cancer Research
Bruce Ratner
Philanthropist and NYC Real Estate Developer
Receiving the Oliver R. Grace Award for Distinguished Service in Advancing Cancer Research
Rafi Ahmed, PhD
Director, Emory Vaccine Center and Professor of Microbiology and Immunology, Emory University
Receiving the William B. Coley Award for Distinguished Research in Tumor Immunology
Thomas F. Gajewski, MD, PhD
Professor, Department of Biology, The University of Chicago
Receiving the William B. Coley Award for Distinguished Research in Tumor Immunology
Shannon Turley, PhD
Principal Scientist, Cancer Immunology, Genentech
Receiving the Frederick W. Alt Award for New Discoveries in Immunology
